Podcast Addict
App
Podcast promotion
العربية (Arabic)
中文 (Chinese)
Hrvatski (Croatian)
Čeština (Czech)
Dansk (Danish)
Nederlands (Dutch)
English
Eesti (Estonian)
Suomi (Finnish)
Français (French)
Deutsch (German)
Ελληνικά (Greek)
עברית (Hebrew)
हिन्दी (Hindi)
Magyar (Hungarian)
Bahasa Indonesia (Indonesian)
Italiano (Italian)
日本語 (Japanese)
한국어 (Korean)
Norsk (Norwegian)
فارسی (Persian)
Polski (Polish)
Português (Portuguese)
Русский (Russian)
Español (Spanish)
Svenska (Swedish)
Українська (Ukrainian)
The Biopharma Pod
By William Reed Business Media
Oct 16 2023
351
Brought to you by the team behind BioPharma-Reporter.com
RSS feed
Share
Share
Copy RSS
Subscribe on Podcast Addict
Episodes
Reviews
You may also like
Podcast: The British start-up taking psychedelic therapy mainstream
Oct 16 2023
28 mins
In our first podcast interview of 2023, BioPharma Reporter spoke with Dr Sarah Bateup, therapy lead at Clerkenwell Health, about the potential of psychedelic medicine and her work within the psychedelic therapy training space.
test
Oct 16 2023
28 mins
What kind of consistency can industry expect from the FDA post pandemic?
Jul 22 2021
15 mins
How the US Food and Drug Administration (FDA) exercises flexibility has been an important and emerging issue for the past several years.
Chicago emerging as a life science and biopharma hub
May 17 2021
14 mins
Many turn to Boston and North Carolina’s Research Triangle to set up life science companies, but Chicago is now also fast becoming a draw in this respect. The city is emerging as a life science and biopharma hub and seems poised for even further growth, in CGT in particular.
Will Biden backed bills boost biosimilars uptake in the US?
May 07 2021
8 mins
Today we are launching a new series called The BioPharma Pod. Kicking off these broadcasts is the hot topic of biosimilars.
Bioproduction bottlenecks increasing due to staff shortages, says report
Aug 15 2017
4 mins
A shortage in expertise is causing bottlenecks in the biomanufacturing space with around half of drugmakers struggling to fill processing positions, an industry report finds.
'The sexiness of the ADC world' - CMOs talk antibody-drug hybrids at CPhI
Oct 29 2013
5 mins
Piramal’s COO Vijay Shah described antibody-drug conjugates (ADCs) as “a concept whose time has come” at the CPhI annual report press conference and recent investors in the technology echo his words.
Better single-use cross flow techs still needed says GE Healthcare
Oct 15 2013
3 mins
The biopharmaceutical manufacturing sector needs better cross flow filtration technologies according to GE Healthcare, which says that advances in bioreactor systems have not been matched downstream.
Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech
Jul 16 2013
5 mins
Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.
Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal
Apr 29 2013
5 mins
ASI has teamed up with Chromatan in order to deliver single-use and column-free capture purification services which could save clients 65% in chromatography costs in clinical manufacturing.
More Episodes
Loading...
Loading...
Loading...